References
- Wedzicha JA, Wilkinson T. Impact of chronic obstructive pulmonary disease exacerbations on patients and payers. Proc Am Thorac Soc 2006; 3:218–221.
- Rodrigo GJ, Rodrigo C, Hall JB. Acute asthma in adults: a review. Chest 2004; 125:1081–1102.
- Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176:532–555.
- Jayaram L, Pizzichini MM, Cook RJ, et al. Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations. Eur Respir J 2006; 27:483–494.
- Papi A, Bellettato CM, Braccioni F, et al. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med 2006; 173:1114–1121.
- Wark PA, Johnston SL, Moric I, Simpson JL, Hensley MJ, Gibson PG. Neutrophil degranulation and cell lysis is associated with clinical severity in virus-induced asthma. Eur Respir J 2002; 19:68–75.
- Parameswaran K, Watson R, Gauvreau GM, Sehmi R, O'Byrne PM. The effect of pranlukast on allergen-induced bone marrow eosinophilopoiesis in subjects with asthma. Am J Respir Crit Care Med 2004; 169:915–920.
- Lemiere C, Romeo P, Chaboillez S, Tremblay C, Malo JL. Airway inflammation and functional changes after exposure to different concentrations of isocyanates. J Allergy Clin Immunol 2002; 110:641–646.
- Brightling CE, Ward R, Wardlaw AJ, Pavord ID. Airway inflammation, airway responsiveness and cough before and after inhaled budesonide in patients with eosinophilic bronchitis. Eur Respir J 2000; 15:682–686.
- Pizzichini MM, Pizzichini E, Clelland L, Efthimiadis A, Pavord I, Dolovich J. Prednisone-dependent asthma: inflammatory indices in induced sputum. Eur Respir J 1999; 13:15–21.
- Pizzichini E, Pizzichini MM, Gibson PG, et al. Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis. Am J Respir Crit Care Med 1998; 158:1511–1517.
- Brightling CD, Monteiro W, Ward R, et al. Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 2000; 357:1480–1485.
- Fujimoto K, Kubo K, Yamamoto H, Yagamuchi S, Matsuzawa Y. Eosinophilic inflammation in the airway is related to glucocorticoid reversibility in patients with pulmonary emphysema. Chest 1999; 115:697–702.
- Dasgupta A, Neighbour H, Nair P. Targeted therapy of bronchitis in obstructive airway diseases. Pharmacol Ther 2013; 140(3):213–222.
- D'silva L, Cook RJ, Allen CJ, Hargreave FE, Parameswaran K. Changing pattern of sputum cell counts during successive exacerbations of airway disease. Respir Med 2007; 101(10):2217–20
- McDonald VM, Higgins I, Wood LG, Gibson PG. Multidimensional assessment and tailored interventions for COPD: respiratory utopia or common sense? Thorax 2013; 68(7):691–694.
- D'silva L, Gafni A, Thabane L, et al. Cost analysis of monitoring asthma treatment using sputum cell counts. Can Respir J 2008; 15(7):370–374.
- Vestbo J1, Hurd SS, Agustí AG, Jones PW, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013; 187(4):347–365.
- Pizzichini E, Pizzichini MM, Efthimiadis A, Hargreave FE, DolovichJ. Measurement of inflammatory indices in induced sputum: effects of selection of sputum to minimize salivary contamination. Eur Respir J 1996; 9:1174–1180.
- Berlyne GS, Efthimiadis A, Hussack P, Groves D, Dolovich J, Hargreave FE. Sputum in asthma: Color versus cell counts. J Allergy Clin Immunol 2000; 105:182–183.
- Lawless JF. Statistical Models and Methods for Lifetime Data, 2nd edition. Hoboken, NJ: John Wiley and Sons, Inc., 2003.
- Sethi S, Murphy TF. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Eng J Med 2008; 359:2355–2365.
- Bafadhel M, McKenna S, Terry S, et al. Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers. Am J Respir Crit Care Med 2011; 184(6):662–671.
- Siva R, Green RH, Brightling CE, et al. Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial. Eur Respir 2007; 29:906–913.
- Bafadhel M, McKenna S, Terry S, et al. Blood eosinophils to direct corticosteroid 424 treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial. Am J Respir Crit Care Med 2012; 186:48–55.
- Aaron SD, Vandemheen KL, Maltais F, et al. TNFα antagonists for acute exacerbations of COPD: a randomised double-blind controlled trial. Thorax 2013; 68:142–148.